I have known of Biospecifics for many years. The company has had its ups and downs but it is finally poised to hit the big time and is a small stock success story. Tomorrow the company will be listed on the NASDAQ Global Market, after a time on the bulletin board. The management has been tenacious in achieving a solid position for BSTC through royalty payments relative to drugs developed by Bio. I own the stock and look forward to the increased visibility the stock will now get being on NASDAQ.